Down-regulation of mir-3928 promoted osteosarcoma growth

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1547-1556

  Xu, Haidong ^a   Liu, Xiaozhou ^a   Zhao, Jianning ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

miR 3928; Osteosarcoma; Therapy; Tumor growth

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE 6; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FORMAZAN; INTERLEUKIN 6 RECEPTOR; MICRORNA; MIR 3928; UNCLASSIFIED DRUG; MICRORNA 3928;

ADOLESCENT; ADULT; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ASSAY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MTT ASSAY; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHOOL CHILD; UPREGULATION; CELL CYCLE; GENE TARGETING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; OSTEOSARCOMA CELL LINE; PROTEIN EXPRESSION; BIOSYNTHESIS; GENETICS; ISOLATION AND PURIFICATION; PATHOLOGY; TUMOR CELL CULTURE; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICRORNAS; OSTEOSARCOMA; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84901299210     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358718     Document Type: Article

References (35)

1. Ottaviani G, Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res 2009;152:3-13.
2. Mirabello L, Troisi RJ, Savage SA: Osteosarcoma incidence and survival r ates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 2009;115:1531-1543.
3. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-790. (Pubitemid 34111386)
4. Lewis VO: What's new in musculoskeletal oncology. J Bone Joint Surg Am 2009;91:1546-1556.
5. Meyers PA, Schwart z CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G , Weiner M, Wells R, Wold L, Womer R, Grier H: Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005 ;23:2004-2011. (Pubitemid 46211380)
6. Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD: Long-term survivals of stage iib osteosarcoma: A 20-year experience in a single institution. Clin Orthop Surg 2011;3: 48-54.
7. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, Yamamoto N: Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 1998;18:657-666. (Pubitemid 28174888)
8. Bolling T, Schuller P, Distelmaier B, Schuck A, Ernst I, Gosheger G, Winkelmann W, Dirksen U, Jurgens H, Kronholz HL, Willich N, Konemann S: Perioperative high-dose rate brachyt herapy using a bendy applicator (flab): Treatment results of 74 patients. Anticancer Res 2008;28:3885-3890.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004. (Pubitemid 38327724)
10. Kim VN, Han J, Siomi MC: Biogenesis of small rnas in animals. Nat Rev Mol Cell Biol 2009;10:126-139.
11. Bartel DP: Micrornas: Target recognition and regulatory functions. Cell 2009;136:215-233.
12. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R: Control of translation and mrna degradation by mirnas and sirnas. Genes Dev 2006;20:515-524. (Pubitemid 43345317)
13. Garzon R Calin GA Croce CM Micrornas in cancer Annu Rev Med 2009 60 167-179.
14. Ding N, Wu X, He J, Chang L, Hu W, Li W, Wang J, Wang T, Zhou G: Detection of novel human mirnas responding to x-r ay irradiation. J Radiat Res 2011;52:425-432.
15. Chang L, Hu W, Ye C, Yao B, Song L, Wu X, Ding N, Wang J, Zhou G: Mir-3928 activates atr pathway by targeting dicer. RNA Biol 2012;9:1247-1254.
16. Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin J, Zhao L, Cai J: Tlr4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of il6 and mir-21. Leukem ia 2011;25:1516-1519.
17. Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao L, Zhao F, Cao F, Lin J, Yang Y, Ni J, Jia J, Wu W, Zhou L, Cui J, Zhang W, Li B, Cai J: Mir-34a in age and tissue related radio-sensitivity and serum mir-34a as a novel indicator of radiation injury. Int J Biol Sci 2011;7:221-233.
18. Wu N, Zhang C, Bai C, Han YP, Li Q: Mir-4782-3p inhibited non-small cell lung cancer growth via usp14. Cell Physiol Biochem 2014;33:457-467.
19. Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q, Li Z, Castellanos-Martin A, Abad M, Cruz-Hernande z JJ, Rodriguez CA, Perez-Losada J, Mao JH, Wei G: C2orf40 suppresses breast cancer cell proliferation and invasion through modulating expression of m phase cell cycle genes. Epigenetics 2013;8:571-583.
20. Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X: Microrna-99a inhibits hepatocellular carcinoma growth and co rrelates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 2011;286:36677-36685.
21. Wu N, Liu C, Bai C, Han YP, Cho WC, Li Q: Over-expression of deubiquitinating enzyme usp14 i n lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int J Mol Sci 2013;14:10749-10760.
22. Wu N, Gu HJ, Li Q: Effects of antidiabetic drug metformin on the migration and inva sion abilities of human pulmonary adenocarcinoma a549 cell line in vitro. J Thorac Dis 2010;2:76-80.
23. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, Atkins JF: A dual-luciferase reporter system for studying recoding signals. RNA 1998;4:479-486. (Pubitemid 28160788)
24. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005;120:15-20. (Pubitemid 40094598)
25. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res 2009;19:92-105.
26. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: Microrna targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 2007;27:91-105. (Pubitemid 46991392)
27. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP: Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other micrornas. Nat Struct Mol Biol 2011;18: 1139-1146.
28. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ: Mirbase: Microrna sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-144.
29. Yarden Y, Sliwkowski MX: Untangling the erbb signalling network. Nat Rev Mol Cell Biol 2001;2:127-137. (Pubitemid 33674041)
30. Fisher MC, Clinton GM, Maihle NJ, Dealy CN: Requirement for erbb2/erbb signaling in developing cartilage and bone. Dev Growth Differ 2007;49:503-513. (Pubitemid 47174205)
31. Jullien N, Maudinet A, Leloutre B, Ringe J, Haupl T, Marie PJ: Downregulation of erbb3 by wnt3a contributes to wnt-induced osteoblast differentiatio n in mesenchymal cells. J Cell Biochem 2012;113:2047-2056.
32. Jullien N, Dieudonne FX, Habel N, Marty C, Modrowski D, Patino A, Lecanda F, Severe N, Marie PJ: Erbb3 silencing reduces o steosarcoma cell proliferation and tumor growth in vivo. Gene 2013;521:55-61.
33. Guo Y, Xu F, Lu T, Duan Z, Zhang Z: Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 2012;38:904-910.
34. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F: Principles of interleukin (il)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20. (Pubitemid 37046923)
35. Kollmann K Heller G Schneckenleithner C Warsch W Scheicher R Ott RG Schafer M Fajmann S Schlederer M Schiefer AI Reichart U Mayerhofer M Hoeller C Zochbauer-Muller S Kerjaschki D Bock C Kenner L Hoefler G Freissmuth M Green AR Moriggl R Busslinger M Malumbres M Sexl V A kinase-independent function of cdk6 links the cell cycle to tumor angiogenesis. Cancer Cell 2013 24 167-181.